Share on StockTwits

HCP (NYSE:HCP) EVP Thomas Klaritch unloaded 40,000 shares of the stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $41.29, for a total transaction of $1,651,600.00. Following the completion of the sale, the executive vice president now directly owns 202,565 shares of the company’s stock, valued at approximately $8,363,909. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of HCP (NYSE:HCP) traded up 0.49% on Wednesday, hitting $40.65. 3,133,572 shares of the company’s stock traded hands. HCP has a 52-week low of $35.50 and a 52-week high of $47.45. The stock’s 50-day moving average is $41.88 and its 200-day moving average is $39.0. The company has a market cap of $18.626 billion and a price-to-earnings ratio of 18.50.

HCP (NYSE:HCP) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.75 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.74 by $0.01. The company had revenue of $530.00 million for the quarter, compared to the consensus estimate of $518.87 million. During the same quarter in the prior year, the company posted $0.74 earnings per share. The company’s quarterly revenue was up 3.7% on a year-over-year basis. On average, analysts predict that HCP will post $3.03 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of HCP in a research note on Monday, June 2nd. They now have a $44.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of HCP from $38.00 to $40.00 in a research note on Monday, May 12th. Finally, analysts at Citigroup Inc. reiterated an “equal weight” rating on shares of HCP in a research note on Wednesday, May 7th. They now have a $42.00 price target on the stock, up previously from $39.00. Eight investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $43.00.

HCP, Inc (NYSE:HCP) is a real estate investment trust (REIT).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.